參考文獻/References:
[1] Benson AB,Venook AP,Alhawary MM,et al.NCCN guidelines insights:Colon cancer version 2[J].Journal Natl Compr Canc Netw,2018,16(4):359-369.
[2] Chen H,Luo J,Guo J.Development and validation of a five-immune gene prognostic risk model in colon cancer[J].BMC Cancer,2020,20(1):395.
[3] 楊 昭,張 嵐.芍藥甘草湯加減對中晚期結腸癌癌性疼痛患者生活質量及生存率的影響[J].遼寧中醫雜志,2020,47(1):99-102,221.
[4] Hsu HH,Chen MC,Baskaran R,et al.Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis[J].Journal Cell Physiol,2018,233(7):5458-5467.
[5] 林紅燕,王 煊,何 聰,等.中藥植物紫草天然產物的生物合成及其功能研究進展[J].遺傳,2021,43(5):459-472.
[6] 張 凡,王綰江,景慧玲.紫草的現代藥理研究及皮膚科中的應用[J].中醫藥導報,2020,26(9):168-172.
[7] 孫艷華,李 明,徐建立,等.紫草素通過激活活性氧自由基誘導大腸癌細胞的凋亡[J].世界中醫藥,2021,16(15):2316-2321.
[8] 姚 越,張 沖,韓 兵,等.紫草素通過抑制人睪丸癌1-10和精原細胞瘤TCAM-2糖酵解誘導細胞死亡[J].南方醫科大學學報,2020,40(9):1288-1294.
[9] 魏毅君,姚 俊,王 捷,等.紫草素抑制胰腺癌細胞增殖并誘導凋亡的研究[J].中華實驗外科雜志,2021,38(1):66-67.
[10] 白 雪,劉建平,郭宇博,等.建立中醫藥臨床實踐指南評價體系的思考[J].中國中藥雜志,2020,45(7):1596-1599.
[11] 張丹參.中藥有效成分的作用機制和物質基礎[J].中國藥理學與毒理學雜志,2019,33(9):656.
[12] 馮曉異,魏寧頤,趙 微,等.三七總皂苷通過ERK/Akt通路改變HepG2/阿霉素細胞耐藥性[J].中國實驗方劑學雜志,2021,27(2):52-59.
[13] 周 昆,閆 焱,李 冰,等.欖香烯對肺腺癌耐藥株SPC-A-1/順鉑耐藥性的逆轉作用及其機制[J].中華實驗外科雜志,2018,35(1):119-122.
[14] 翁旭東.槲皮素通過Bim-Bak/Bax途徑提高順鉑耐藥膀胱癌細胞對順鉑敏感性的研究[J].中國現代應用藥學,2017,34(4):515-520.
[15] Zhang S,Gao Q,Li W,et al.Shikonin inhibits cancer cell cycling by targeting Cdc25s[J].BMC Cancer,2019,19(1):20.
[16] Chen Y,Zheng L,Liu J,et al.Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways[J].Int Immunopharmacol,2014,21(2):447-455.
[17] Shi W,Men L,Pi X,et al.Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL-6/STAT3 signaling pathway[J].Int Journal Oncol,2021,59(6):99.
[18] Wang T,Jin H,Hu J,et al.COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling[J].Journal Exp Clin Cancer Res,2020,39(1):148.
[19] Zhang S,Ma H,Zhang D,et al.LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling[J].Cell Death Dis,2018,9(7):742.
[20] Xu L,Tong X,Zhang S,et al.ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma[J].Tumour Biol,2016,37(10):13669-13677.
[21] 馮方方,吳 瓊,魯昌輝.清宮排毒湯治療宮頸癌療效及對患者腫瘤細胞上皮間質轉化的影響[J].陜西中醫,2021,42(2):187-191.
[22] Bae YK,Choi JE,Kang SH,et al.Epithelial-mesenchymal transition phenotype is associated with clinicopathological factors that indicate aggressive biological behavior and poor clinical outcomes in invasive breast cancer[J].Journal Breast Cancer,2015,18(3):256-263.
[23] 唐 曦,胡 婭,徐炎華,等.MiR-498通過下調FOXM1抑制肺腺癌細胞上皮充質細胞轉化[J].山東大學學報:醫學版,2017,55(4):39-43.
[24] Peng YS,Syu JP,Wang SD,et al.BSA-bounded p-cresyl sulfate potentiates the malignancy of bladder carcinoma by triggering cell migration and EMT through the ROS/Src/FAK signaling pathway[J].Cell Biol Toxicol,2020,36(4):287-300.
[25] Wilson C,Nicholes K,Bustos D,et al.Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition[J].Oncotarget,2014,5(17):7328-7341.